UnitedHealth Group reported a strong Q1 performance with revenue growth exceeding expectations, higher retention rates, and an upward revision of revenue and earnings outlooks for 2017. Although there's uncertainty around healthcare and tax policy changes, these results indicate underlying business strength and operational improvements. However, the guidance for modest revenue growth and the immediate absence of clarity regarding policy changes might limit short-term investor enthusiasm.

[-1]